NA Proactive news snapshot: Humanigen, NetCents, Gold Resource, XPhyto Therapeutics, NexTech AR ...

Humanigen Inc (NASDAQ:HGEN) (FRA:0KB2) announced Tuesday that it has signed a licensing agreement with Telcon RF Pharmaceutical Inc and KPM Tech Co Ltd for the development and commercialization rights to its drug lenzilumab as a coronavirus (COVID-19) treatment in South Korea and the Philippines. The deal is worth as much as $20 million, including $6 million in an upfront payment when the agreement is executed and $14 million in two payments when certain achievement milestones are met by Humanigen in the US. Telcon and KPM Tech will be responsible for gaining regulatory approval and subsequent commercialization of lenzilumab in its territories, and Humanigen will earn double-digit royalties following such approval on net sales after commercialization.  NetCents Technology Inc (CSE:NC) (OTCQB:NTTCF) (FRA:26N), a cryptocurrency payments company, announced on Tuesday that it is adding the ability for NetCents users to purchase cryptocurrency by dint of a credit card on the NC Exchange. The Vancouver-based company noted that there are a limited number of platforms that are approved by the card companies for purchasing cryptocurrency. “NetCents is now approved, which is a testament to the safety that is inherent in the NetCents platform,” said the company in a statement. The company said the move would be benefecial as it would provide a new way for users to be able to load funds into their NetCents wallet, making it easier for users to purchase cryptocurrency. In addition, it will provide NetCents users with fast and easy access to cryptocurrency, in the most secure way possible. Gold Resource Corporation (NYSEAMERICAN:GORO) (FRA:GIH) told investors it generated free cash flow at both its mining operations in the third quarter this year despite a two-month shut-down of operations in Mexico from April. The company is a gold and silver producer and explorer with mines in Oaxaca, Mexico and Nevada in the US. In the US, the firm posted record gold production in the three months to end September, at 7,847 gold ounces, up 51% compared to the previous quarter. Meanwhile, over in Mexico, the firm produced 4,728 ounces of gold, 324,592 ounces of silver, 428 tonnes of copper, 2,157 tonnes of lead and 5,538 tonnes of zinc in the third quarter. Net income for the period came in at around $5 million, up from $2.9 million in the same quarter of 2019, on revenue of $42.2 million, up from around $40 million in the same period of 2019. XPhyto Therapeutics Corp (CSE:XPHY) (OTCMKTS:XPHYF) (FRA:4XT) said Tuesday that its German subsidiary Vektor Pharma TF GmbH will start to develop a process to manufacture psilocybin as a certified active pharmaceutical ingredient (API). The subsidiary inked a research agreement with a leading German university that will see Vektor exclusively develop a proprietary process for industrial production of psilocybin, Vancouver-based XPhyto told investors. In a statement, XPhyto said it is currently focused on securing industrial-scale production of psychedelic APIs and standardizing drug formulations. A biotechnology production program started last month and is expected to finish around September 2021.  NexTech AR Solutions Corp (OTCQB:NEXCF) (CSE:NTAR) (FRA:N29) announced Friday that it is expanding its services into the Asia-Pacific market after establishing a presence in Singapore. To support this expansion, NexTech said it has hired Yau Boon Lim, a technology industry veteran with over 25 years’ experience in strategy, planning, marketing, operations, and business management for various industries in the Asia-Pacific market. Lim has held leadership positions within global enterprise technology companies, driving marketing and strategies for blue-chip global tech companies, including IBM, where he led marketing management, Motorola where he was head of strategy and planning, and SAP where he was vice president of marketing for the Asia-Pacific market. Lim will be based out of Singapore. In this new role, Lim will be responsible for quickly establishing NexTech’s presence in the Asia-Pacific market through strategic channel partnerships. Lim will also drive the company’s marketing efforts across Asia and will build out the team to support service requests across the region by the end of 2020. O3 Mining Inc (CVE:OIII) announced new drilling results from the Malartic Property in Val D'Or, Quebec, which included 2.9 grams per tonne (g/t) gold over 14.2 metres starting at 25 meters below surface. O3 Mining’s latest drill results are part of its fully-funded 150,000 metre drilling program, which is focused on expanding mineralization outside of the proposed pit areas outlined in the Preliminary Economic Assessment (PEA) released on September 8 , 2020. The 2020-2021 drilling program encompasses 45,000 metres on the Malartic property to test extensions of the deposits and zones outside of the PEA pit areas of the Marban project. Jay Taylor, in the October 15, 2020, edition of 'Gold, Energy & Tech Stocks', says buy Fury Gold Mines Ltd. (CVE:FURY). He previously recommended predecessor company, Auryn Resources, nine times from March 16, 2015, to May 14, 2020, at prices ranging from $1.25 to $3.19. On October 9, 2020, Auryn completed a reorganization that created three companies, one of which was Fury (the other two are not publicly listed). For portfolio purposes, Taylor sold his $9,000 investment in Auryn on October 9, 2020, at $3.23, for a profit of $7,243. Now the focus turns to Fury, he said, with its core assets comprising the Eau Claire gold project in Quebec, the Committee Bay gold project in Nunavut and the Homestake Ridge gold project in British Columbia's Golden Triangle. Taylor said all three projects have "considerable growth potential." He is optimistic that Fury's "strong management team" is "setting the stage for some very positive developments over the next 12 months or so." Aftermath Silver Ltd (CVE:AAG) said the TSX Venture Exchange has accepted for filing an acquisition agreement dated September 30, 2020, between the company and SSR Mining Inc., whereby the company will acquire 100% of the Berenguela silver-copper project, located in Puno, Peru, through the purchase of 100%  of SSR's shares in the Peruvian holding company, Sociedad Mineral Berenguela S.A. The aggregate consideration is US$13 million, 3,828,972 common shares with a deemed price per share of 78.35 cents in the first year, and the completion of a preliminary feasibility study and filing of a National Instrument 43-101 report in the fifth year. The company will grant SSR a net smelter return (NSR) royalty, of which a 1% NSR royalty will be on all mineral production when the silver market price is up to and including US $25 per ounce, and a 1.25% NSR royalty will be on all mineral production when the silver market price is over US$25 per ounce and the copper market price is over US$2 per pound. Elysium Mining Ltd. (Peter Voulgaris) will receive a finder's fee of 191,448 common shares with a deemed price per share of 78.35 cents. TRACON Pharmaceuticals (NASDAQ:TCON) will reveal its 3Q 2020 results on Tuesday November 10 after the market closes. The San Diego-based firm’s management will also host a conference call to discuss the results at 4:30pm ET. Participants may log on by dialing (855) 779-9066 (Domestic) or (631) 485-4859 (International) and using the passcode 7399456. TRACON develops targeted therapies for cancer utilizing a capital efficient, CRO independent, product development platform.